For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
Blog
Department of Health and Human Services Needs to Correct Record on Marijuana
Regulators at the federal Drug Enforcement Agency (DEA) had an opportunity in 2016 to move marijuana into a less restrictive category of controlled substances. This…
The Tennessee Star
Trump Administration Ends Unions ‘Skimming’ $100 Million A Year From Medicaid
The Tennessee Star cites Policy Analyst Trey Kovacs on Medicaid rule change made by the Trump Administration. “Congress created Medicaid to exclusively fund…
Blog
Trump Administration Ends Homecare Providers Dues Skim
Since 2000, state governments have diverted $1.4 billion from homecare providers and handed it to labor unions, according to the Freedom Foundation. For over a…
News Release
McConnell Plan to Raise Nicotine Access to Age 21 Could Backfire
Citing health concerns about youth vaping, Senate Majority Leader Mitch McConnell (R-Kentucky) announced legislation to raise the nationwide minimum age to buy tobacco products from…
Medium
The FDA’s Runaway Trolley Problem
If you’ve ever participated in a thought experiment, you know how fun that can be. The most famous is the Trolley Problem, entertainingly portrayed by…
American Chemistry
IRIS: Bad Science, Real World Consequences
American Chemistry cited CEI’s publication by Senior Fellow Angela Logomasini on the IRIS. In February 2019 the Competitive Enterprise Institute (CEI) provided some important…